⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VKTX News
Viking Therapeutics, Inc
Viking Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com
VKTX
Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients
businesswire.com
VKTX
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
prnewswire.com
PODD
VKTX
AMRX
PBH
Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
prnewswire.com
VKTX
Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica
globenewswire.com
VKTX
LLY
NVO
MRK
FSK
TSN
KDP
PEP
MNDO
THG
ENTX
RANI
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
prnewswire.com
VKTX
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
prnewswire.com
VKTX
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
prnewswire.com
VKTX
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
VKTX
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
prnewswire.com
NVO
ELDN
VKTX
TNDM